{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31415655", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "15"}], "Language": ["eng"], "ELocationID": ["e0221199", "10.1371/journal.pone.0221199"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "14", "Issue": "8", "PubDate": {"Year": "2019"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial.", "Pagination": {"StartPage": "e0221199", "MedlinePgn": "e0221199"}, "Abstract": {"AbstractText": ["In Asian countries, many patients with type 2 diabetes fail to achieve controlled glycated hemoglobin (HbA1c) levels while taking several classes of oral hypoglycemic agents (OHAs). Traditional Chinese medicine could be an alternative therapeutic option for poorly controlled type 2 diabetes. YH1 is a concentrated Chinese herbal extract formula that combines Rhizoma Coptidis and Shen-Ling-Bai-Zhu-San. This randomized, double-blind, placebo-controlled pilot study evaluated YH1 as an add-on medication for poorly controlled type 2 diabetes.", "Forty-six patients with poorly controlled type 2 diabetes were randomly assigned 1:1 to the YH1 or placebo group. Before the trial, all subjects had received three or more classes of OHAs with HbA1c > 7.0% (53 mmol/mol) and a body mass index \u2265 23 kg/m2. During the 12-week trial, participants continued to take OHAs without any dose or medication changes. The primary endpoint was the percentage change in HbA1c level. Per-protocol analysis was applied to the final evaluation.", "At week 12, there was an 11.1% reduction in HbA1c from baseline and a 68.9% increase in homeostatic model assessment (HOMA) of \u03b2 cell function in the YH1 group, which also exhibited significant reductions in two-hour postprandial glucose (-26.2%), triglycerides (-29.5%), total cholesterol (-21.6%), low-density lipoprotein cholesterol (-17.4%), body weight (-0.5%), and waist circumference (-1.1%). The changes in fasting plasma glucose, HOMA insulin resistance and symptom scores were not significantly different between the YH1 and placebo groups. No serious adverse events occurred during this clinical trial.", "This pilot study indicates that YH1 together with OHAs can improve hypoglycemic action and \u03b2-cell function in overweight/obese patients with poorly controlled type 2 diabetes. YH1 is a safe add-on medication for OHAs and has beneficial effects on weight control and lipid metabolism. A larger study population with longer treatment and follow-up periods is required for further verification."]}, "AuthorList": [{"Identifier": ["0000-0001-7422-120X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan."}, {"Identifier": [], "Affiliation": "Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Huang", "ForeName": "Yueh-Hsiang", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Chen", "ForeName": "Szu-Tah", "Initials": "ST"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Liu", "ForeName": "Feng-Hsuan", "Initials": "FH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Hsieh", "ForeName": "Sheng-Hwu", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}, {"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Lin", "ForeName": "Chia-Hung", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Liou", "ForeName": "Miaw-Jene", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Wang", "ForeName": "Chih-Ching", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan."}], "LastName": "Huang", "ForeName": "Chung-Huei", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan."}, {"Identifier": [], "Affiliation": "Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}, {"Identifier": [], "Affiliation": "School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Liu", "ForeName": "Geng-Hao", "Initials": "GH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Lin", "ForeName": "Jr-Rung", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biostatistics and Informatics Unit, Clinical Trial Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Yang", "ForeName": "Lan-Yan", "Initials": "LY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biostatistics and Informatics Unit, Clinical Trial Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Hsu", "ForeName": "Tzu-Yang", "Initials": "TY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Brion Research Institute of Taiwan, Taipei City, Taiwan."}], "LastName": "Lee", "ForeName": "Ming-Chung", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States of America."}], "LastName": "Huang", "ForeName": "Chun-Teng", "Initials": "CT"}, {"Identifier": ["0000-0001-9862-1961"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan."}, {"Identifier": [], "Affiliation": "School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}], "LastName": "Wu", "ForeName": "Yi-Hong", "Initials": "YH"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycated Hemoglobin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "hemoglobin A1c protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "shen ling bai zhu"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["chemistry"], "DescriptorName": "Araceae"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glycated Hemoglobin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice. 2017;128:40\u201350. 10.1016/j.diabres.2017.03.024", "ArticleIdList": ["10.1016/j.diabres.2017.03.024", "28437734"]}, {"Citation": "Group IDFGD. Global Guideline for Type 2 Diabetes. Diabetes Research and Clinical Practice. 2014;104(1):1\u201352. 10.1016/j.diabres.2012.10.001", "ArticleIdList": ["10.1016/j.diabres.2012.10.001", "24508150"]}, {"Citation": "Ji LN, Lu JM, Guo XH, Yang WY, Weng JP, Jia WP, et al. Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health. 2013;13(1):602 10.1186/1471-2458-13-602", "ArticleIdList": ["10.1186/1471-2458-13-602", "PMC3729491", "23800082"]}, {"Citation": "Chuang LM, Tsai ST, Huang BY, Tai TY. The current state of diabetes management in Taiwan. Diabetes Research and Clinical Practice. 2001;54:55\u201365. 10.1016/S0168-8227(01)00310-2", "ArticleIdList": ["10.1016/S0168-8227(01)00310-2", "11580970"]}, {"Citation": "Scheen AJ. \u2018Treatment-resistant\u2019 type 2 diabetes: Which definition for clinical practice? Diabetes & Metabolism. 2017;43(4):295\u20137. 10.1016/j.diabet.2017.04.009", "ArticleIdList": ["10.1016/j.diabet.2017.04.009", "28552491"]}, {"Citation": "Tong X-L, Dong L, Chen L, Zhen Z. Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future. The American Journal of Chinese Medicine. 2012;40(05):877\u201386. 10.1142/s0192415x12500656 .", "ArticleIdList": ["10.1142/s0192415x12500656", "22928822"]}, {"Citation": "Ji L, Tong X, Wang H, Tian H, Zhou H, Zhang L, et al. Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial. PLoS ONE. 2013;8(2):e56703 10.1371/journal.pone.0056703 PMC3584095.", "ArticleIdList": ["10.1371/journal.pone.0056703", "PMC3584095", "23460810"]}, {"Citation": "Meijun L, Zhicheng L, Bin X, Wei Z, Jianwei C. Review of systematic reviews and Meta-analyses investigating Traditional Chinese Medicine treatment for type 2 diabetes mellitus. Journal of Traditional Chinese Medicine. 2016;36(5):555\u201363. 10.1016/S0254-6272(16)30074-7.", "ArticleIdList": ["10.1016/S0254-6272(16)30074-7", "29932626"]}, {"Citation": "Huang C-Y, Tsai Y-T, Lai J-N, Hsu F-L. Prescription Pattern of Chinese Herbal Products for Diabetes Mellitus in Taiwan: A Population-Based Study. Evidence-Based Complementary and Alternative Medicine. 2013;2013:10 10.1155/2013/201329", "ArticleIdList": ["10.1155/2013/201329", "PMC3703417", "23843864"]}, {"Citation": "Ma H, He K, Zhu J, Li X, Ye X. The anti-hyperglycemia effects of Rhizoma Coptidis alkaloids: A systematic review of modern pharmacological studies of the traditional herbal medicine. Fitoterapia. 2019;134:210\u201320. 10.1016/j.fitote.2019.03.003", "ArticleIdList": ["10.1016/j.fitote.2019.03.003", "30836124"]}, {"Citation": "Yin J, Ye J, Jia W. Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica B. 2012;2(4):327\u201334. 10.1016/j.apsb.2012.06.003.", "ArticleIdList": ["10.1016/j.apsb.2012.06.003"]}, {"Citation": "Zhang Q, Xiao X, Li M, Li W, Yu M, Zhang H, et al. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine. BMC Complementary and Alternative Medicine. 2014;14:188\u2013. 10.1186/1472-6882-14-188 PMC4057525.", "ArticleIdList": ["10.1186/1472-6882-14-188", "PMC4057525", "24912407"]}, {"Citation": "Cicero A, Ertek S. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clinical Lipidology. 2009;4(5):553\u201363. 10.2217/clp.09.41", "ArticleIdList": ["10.2217/clp.09.41"]}, {"Citation": "Shishtar E, Sievenpiper JL, Djedovic V, Cozma AI, Ha V, Jayalath VH, et al. The Effect of Ginseng (The Genus Panax) on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. PLoS ONE. 2014;9(9):e107391 10.1371/journal.pone.0107391 PMC4180277.", "ArticleIdList": ["10.1371/journal.pone.0107391", "PMC4180277", "25265315"]}, {"Citation": "Go HK RM, Kim GB, Na CS, Song CH, Kim JS, Kim SJ, Kang HS. Antidiabetic Effects of Yam (Dioscorea batatas) and Its Active Constituent, Allantoin, in a Rat Model of Streptozotocin-Induced Diabetes. Nutrients. 2015;7(10):8532\u201344. 10.3390/nu7105411 PMC4632431.", "ArticleIdList": ["10.3390/nu7105411", "PMC4632431", "26501316"]}, {"Citation": "Song MY, Jung HW, Kang SY, Park Y-K. Atractylenolide III Enhances Energy Metabolism by Increasing the SIRT-1 and PGC1\u03b1 Expression with AMPK Phosphorylation in C2C12 Mouse Skeletal Muscle Cells. Biological and Pharmaceutical Bulletin. 2017;40(3):339\u201344. 10.1248/bpb.b16-00853", "ArticleIdList": ["10.1248/bpb.b16-00853", "28250276"]}, {"Citation": "Li TH HC, Chang CLT, Yang WC. Anti-Hyperglycemic Properties of Crude Extract and Triterpenes from Poria cocos. Evidence-based Complementary and Alternative Medicine: eCAM. 2011;2011:128402 10.1155/2011/128402 PMC2949581.", "ArticleIdList": ["10.1155/2011/128402", "PMC2949581", "20924500"]}, {"Citation": "Barba C, Cavalli-Sforza, Tommaso, Cutter, Jeffery, Darnton-Hill, et al. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363(9403):157\u201363. 10.1016/S0140-6736(03)15268-3", "ArticleIdList": ["10.1016/S0140-6736(03)15268-3", "14726171"]}, {"Citation": "Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ. Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009\u20132011. Journal of Diabetes and its Complications. 2016;30(2):212\u201320. 10.1016/j.jdiacomp.2015.11.016", "ArticleIdList": ["10.1016/j.jdiacomp.2015.11.016", "26689451"]}, {"Citation": "Tsai ST, Pathan F, Ji L, Yeung VTF, Chadha M, Suastika K, et al. First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. Journal of Diabetes. 2011;3(3):208\u201316. 10.1111/j.1753-0407.2011.00137.x PMC3178786.", "ArticleIdList": ["10.1111/j.1753-0407.2011.00137.x", "PMC3178786", "21631903"]}, {"Citation": "Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, et al. Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience. Diabetes, metabolic syndrome and obesity: targets and therapy. 2017;10:521\u201332. Epub 2017/12/26. 10.2147/dmso.S143046", "ArticleIdList": ["10.2147/dmso.S143046", "PMC5733912", "29276400"]}, {"Citation": "Yin J, Xing H, Ye J. Efficacy of Berberine in Patients with Type 2 Diabetes. Metabolism: clinical and experimental. 2008;57(5):712\u20137. 10.1016/j.metabol.2008.01.013 PMC2410097.", "ArticleIdList": ["10.1016/j.metabol.2008.01.013", "PMC2410097", "18442638"]}, {"Citation": "Dong H, Zhao Y, Zhao L, Lu F. The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Planta Med. 2013;79(06):437\u201346. Epub 19.03.2013. 10.1055/s-0032-1328321", "ArticleIdList": ["10.1055/s-0032-1328321", "23512497"]}, {"Citation": "Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine. 2004;10:1344 10.1038/nm1135", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Wang Y, Yi X, Ghanam K, Zhang S, Zhao T, Zhu X. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. Metabolism\u2014Clinical and Experimental. 2014;63(9):1167\u201377. 10.1016/j.metabol.2014.05.013", "ArticleIdList": ["10.1016/j.metabol.2014.05.013", "25002181"]}, {"Citation": "Zhang Y ZH. Microbiota associated with type 2 diabetes and its related complications. Food Science and Human Wellness. 2013;2(3):167\u201372. 10.1016/j.fshw.2013.09.002.", "ArticleIdList": ["10.1016/j.fshw.2013.09.002"]}, {"Citation": "Wang Y, Shou J-W, Li X-Y, Zhao Z-X, Fu J, He C-Y, et al. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism\u2014Clinical and Experimental. 2017;70:72\u201384. 10.1016/j.metabol.2017.02.003", "ArticleIdList": ["10.1016/j.metabol.2017.02.003", "28403947"]}, {"Citation": "Priyadarshini M, Wicksteed B, Schiltz GE, Gilchrist A, Layden BT. SCFA Receptors in Pancreatic Beta Cells: Novel Diabetes Targets? Trends in endocrinology and metabolism: TEM. 2016;27(9):653\u201364. 10.1016/j.tem.2016.03.011 PMC4992600.", "ArticleIdList": ["10.1016/j.tem.2016.03.011", "PMC4992600", "27091493"]}, {"Citation": "Dong H, Wang N, Zhao L, Lu F. Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine. 2012;2012:12 10.1155/2012/591654", "ArticleIdList": ["10.1155/2012/591654", "PMC3478874", "23118793"]}, {"Citation": "Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterology & Motility. 2004;16(4):413\u20139. 10.1111/j.1365-2982.2004.00530.x", "ArticleIdList": ["10.1111/j.1365-2982.2004.00530.x", "15305996"]}, {"Citation": "Lv W, Liu C, Ye C, Sun J, Tan X, Zhang C, et al. Structural modulation of gut microbiota during alleviation of antibiotic-associated diarrhea with herbal formula. International Journal of Biological Macromolecules. 2017;105:1622\u20139. 10.1016/j.ijbiomac.2017.02.060", "ArticleIdList": ["10.1016/j.ijbiomac.2017.02.060", "28219687"]}, {"Citation": "Wang KT, Chen LG, Wu CH, Chang CC, Wang CC. Gastroprotective activity of atractylenolide III from Atractylodes ovata on ethanol\u2010induced gastric ulcer in vitro and in vivo. Journal of Pharmacy and Pharmacology. 2010;62(3):381\u20138. 10.1211/jpp.62.03.0014", "ArticleIdList": ["10.1211/jpp.62.03.0014", "20487223"]}]}], "History": [{"Year": "2018", "Month": "10", "Day": "30"}, {"Year": "2019", "Month": "7", "Day": "19"}, {"Year": "2019", "Month": "8", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["31415655", "PMC6695147", "10.1371/journal.pone.0221199", "PONE-D-18-31211"]}}]}